広島大学

基本情報

学位

• 博士（医学）　(広島大学)

研究活動

学術論文（★は代表的な論文）

1. Association between prognosis and lymph node status using 18F-fluorodeoxyglucose-positron emission tomography in esophageal squamous cell carcinoma treated with esophagectomy post-neoadjuvant chemotherapy, World J Surg ., 48巻, 3号, pp. 650-661, 202403
2. Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery, World J Surg ., 48巻, 2号, pp. 416-426, 202402
3. The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma, Surg Today ., 54巻, 1号, pp. 53-63, 202401
4. Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma, Onco Targets Ther ., 20230410
5. Relationship of Immune-Related Adverse Events with Tumor Response and Prognosis in Esophageal Squamous Cell Carcinoma Following Nivolumab Monotherapy, CANCERS, 16巻, 20号, 202410
   DOIを用いた論文検索結果へのリンク
6. Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy, WORLD JOURNAL OF SURGERY, 48巻, 7号, pp. 1700-1709, 202407
   DOIを用いた論文検索結果へのリンク
7. Association between prognosis and lymph node status using ¹⁸F-fluorodeoxyglucose-positron emission tomography in esophageal squamous cell carcinoma treated with esophagectomy post-neoadjuvant chemotherapy, WORLD JOURNAL OF SURGERY, 48巻, 3号, pp. 650-661, 202403
   DOIを用いた論文検索結果へのリンク
8. Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma, Front Oncol ., 20230417